Sofie Martens

Journal Article
A1
open access

MLKL deficiency in BrafV600EPten-/- melanoma model results in a modest delay of nevi development and reduced lymph node dissemination in male mice

Sofie Martens, Nozomi Takahashi (UGent) , Gillian Blancke (UGent) , Niels Vandamme (UGent) , Hanne Verschuere, Tatyana Divert (UGent) , Marnik Vuylsteke, Geert Berx (UGent) and Peter Vandenabeele (UGent)

(2022) CELL DEATH & DISEASE. 13(4).

Add to list

Journal Article
A1
open access

Executioner caspases 3 and 7 are dispensable for intestinal epithelium turnover and homeostasis at steady state

Farzaneh Ghazavi (UGent) , Jelle Huysentruyt, Jordy De Coninck (UGent) , Stephanie Kourula (UGent) , Sofie Martens, Behrouz Hassannia (UGent) , Tim Wartewig, Tatyana Divert (UGent) , Ria Roelandt (UGent) , Bastian Popper, et al.

(2022) PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 119(6).

Add to list

MLKL in cancer : more than a necroptosis regulator

Sofie Martens, Jolien Bridelance (UGent) , Ria Roelandt (UGent) , Peter Vandenabeele (UGent) and Nozomi Takahashi (UGent)

(2021) CELL DEATH AND DIFFERENTIATION. 28(6). p.1757-1772

Add to list

Journal Article
A1
open access

Ionizing radiation results in a mixture of cellular outcomes including mitotic catastrophe, senescence, methuosis, and iron-dependent cell death

Sandy Adjemian Catani (UGent) , Teodora-Eugenia Oltean, Sofie Martens, Bartosz Wiernicki, Vera Goossens (UGent) , Tom Vanden Berghe (UGent) , Benjamin Cappe, Maria Ladik (UGent) , Franck Riquet (UGent) , Liesbeth Heyndrickx (UGent) , et al.

(2020) CELL DEATH & DISEASE. 11(11).

Add to list

Inhibitors targeting RIPK1/RIPK3 : old and new drugs

Sofie Martens, Sam Hofmans, Wim Declercq (UGent) , Koen Augustyns and Peter Vandenabeele (UGent)

(2020) TRENDS IN PHARMACOLOGICAL SCIENCES. 41(3). p.209-224

Add to list

PhD Thesis

Necroptotic proteins in diseases : targeting RIP kinases in inflammatory disorders and exploring the role of MLKL in melanoma development

Sofie Martens

(2019)

Add to list

Journal Article
A1
open access

RIPK1-dependent cell death : a novel target of the Aurora kinase inhibitor Tozasertib (VX-680)

Sofie Martens, Vera Goossens (UGent) , Lars Devisscher, Sam Hofmans, Polien Claeys, Marnik Vuylsteke (UGent) , Nozomi Takahashi (UGent) , Koen Augustyns and Peter Vandenabeele (UGent)

(2018) CELL DEATH & DISEASE. 9.

Add to list

Tozasertib analogues as inhibitors of necroptotic cell death

Sam Hofmans, Lars Devisscher, Sofie Martens, Dries Van Rompaey, Kenneth Goossens, Tatyana Divert (UGent) , Wim Nerinckx (UGent) , Nozomi Takahashi (UGent) , Hans De Winter, Pieter Van der Veken, et al.

(2018) JOURNAL OF MEDICINAL CHEMISTRY. 61(5). p.1895-1920

Add to list

Ionizing radiation-induced cell death

Sandy Adjemian Catani (UGent) , Katrien Vandecasteele (UGent) , Sofie Martens, Bartosz Wiernicki, Tania Love Aaes (UGent) , Dmitri Krysko (UGent) and Peter Vandenabeele (UGent)

(2017) European Cell Death Organization, 25th Conference, Abstracts.

Add to list

Journal Article
A1
open access

Sorafenib inhibits therapeutic induction of necroptosis in acute leukemia cells

Friederike Feldmann, Barbara Schenk, Sofie Martens, Peter Vandenabeele (UGent) and Simone Fulda

(2017) ONCOTARGET. 8(40). p.68208-68220

Academic Bibliography

Sofie Martens

MLKL deficiency in BrafV600EPten-/- melanoma model results in a modest delay of nevi development and reduced lymph node dissemination in male mice

Executioner caspases 3 and 7 are dispensable for intestinal epithelium turnover and homeostasis at steady state

MLKL in cancer : more than a necroptosis regulator

Ionizing radiation results in a mixture of cellular outcomes including mitotic catastrophe, senescence, methuosis, and iron-dependent cell death

Inhibitors targeting RIPK1/RIPK3 : old and new drugs

Necroptotic proteins in diseases : targeting RIP kinases in inflammatory disorders and exploring the role of MLKL in melanoma development

RIPK1-dependent cell death : a novel target of the Aurora kinase inhibitor Tozasertib (VX-680)

Tozasertib analogues as inhibitors of necroptotic cell death

Ionizing radiation-induced cell death

Sorafenib inhibits therapeutic induction of necroptosis in acute leukemia cells

Contents

Support

Contact